This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A 2-Year Follow-up

Christian von Scheele, MD; Viktor Kempi, PhD, MD

Arch Neurol. 1990;47(11):1223-1224.

Abstract
• Thirty patients with restless legs syndrome, who initially had all responded well to treatment with levodopa and benserazide, were studied as to the long-term effect of the drugs (at least 2 years). During the 2-year period, two patients were switched from levodopa to bromocriptine. Two patients no longer needed levodopa; one of them had developed paraplegia and in the other the symptoms of restless legs syndrome had disappeared completely. The remaining 26 patients continued to use levodopa. Eight patients maintained the original dose, nine had to use an increased dose, and nine found a decreased dose to be sufficient. The only side effect was transient nausea reported by two of the 30 patients. The study showed that the relief of symptoms of restless legs syndrome by dopaminergic drugs does not wear off with the passage of time, that side effects are minimal even with long-term use, and that the dose needed to obtain relief may increase as well as decrease.

Author Affiliations
From the Departments of Medicine (Dr Scheele) and Radiophysics (Dr Kempi), Sjukhuset, Ostersund, Sweden.

Footnotes
Accepted for publication February 22, 1990.

Reprint requests to the Department of Medicine, Sjukhuset, S831 83, Ostersund, Sweden (Dr von Scheele).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Restless Legs Syndrome
Ryan and Slevin
Journal of Pharmacy Practice 2007;20:430-448.
ABSTRACT  

Restless legs syndrome.
Ryan and Slevin
Am J Health Syst Pharm 2006;63:1599-1612.
ABSTRACT | FULL TEXT  

Restless legs syndrome: Treatment with dopaminergic agents
Comella
Neurology 2002;58:S87-92.
ABSTRACT | FULL TEXT  

Long-term effects of pergolide in the treatment of restless legs syndrome
Stiasny et al.
Neurology 2001;56:1399-1402.
ABSTRACT | FULL TEXT  

Restless legs syndrome improved by pramipexole: A double-blind randomized trial
Montplaisir et al.
Neurology 1999;52:938-938.
ABSTRACT | FULL TEXT  

Restless Legs Syndrome: A Review
O'Keeffe
Arch Intern Med 1996;156:243-248.
ABSTRACT